INTERNATIONAL ONCOLOGICAL COMPENDIUM (IOC)

1ST International Edition 2022

What is this iOC 2022 eBook about?

INTERNATIONAL GROUP FOR SUPPORTIVE CANCER CARE STUDY publishes the “IOC 2022” 

As a guide to help professionals. This compendium is intended to be the first updated review of most of the clinical situations that cancer patients may present. It identifies the clinical picture and the therapeutic orientation, with the degrees of recommendation and evidence, as well as the direct bibliographic reference for each statement.

We took a multidisciplinary approach, with the collaboration of 261 authors from 9 countries, 45 hospitals and 19 medical and non-medical specialties.
This compendium (IOC 2022) is the result of the effort and innovative spirit of its authors, will be updated every two years.
The first international edition of cancer care support based on real world evidence (RWE) contains all the latest news in cancer care support treatment and assigns levels of evidence and grades of recommendation so that the reader can obtain
a quick impression and certainty of each of the treatments and strategies presented.
*The GRADE and OXFORD scales have been used for the levels of evidence.

DOWNLOAD

*This eBook is for sale according to prices established by geographical location

Buy the eBook NOW and we will send you the physical book wherever you need it!

What is this iOC 2022 eBook about?

INTERNATIONAL GROUP FOR SUPPORTIVE CANCER CARE STUDY publishes the “IOC 2022” 

As a guide to help professionals. This compendium is intended to be the first updated review of most of the clinical situations that cancer patients may present. It identifies the clinical picture and the therapeutic orientation, with the degrees of recommendation and evidence, as well as the direct bibliographic reference for each statement.

We took a multidisciplinary approach, with the collaboration of 261 authors from 9 countries, 45 hospitals and 19 medical and non-medical specialties.
This compendium (IOC 2022) is the result of the effort and innovative spirit of its authors, will be updated every two years.
The first international edition of cancer care support based on real world evidence (RWE) contains all the latest news in cancer care support treatment and assigns levels of evidence and grades of recommendation so that the reader can obtain
a quick impression and certainty of each of the treatments and strategies presented.
*The GRADE and OXFORD scales have been used for the levels of evidence.

GO TO THE WEBAPP

*This eBook is for sale according to prices established by geographical location

Buy the eBook NOW and we will send you the physical book wherever you need it!

* GRADE SYSTEM (ADAPTED)

Oxford Center for Evidence-Based-Medicine Hierarchy (adapted)

Adapted from: “levels of Evidence (Oxford Centre for Evidence-based Medicine-March 2009)

The toxicity grades follow the CTCAE v5.0 classification.

GUIDE INDEX

1.Oncologic Pain
1.1. NEUROPATHIC PAIN
1.2. SOMATIC PAIN
1.3. VISCERAL PAIN
1.4. IRRUPTIVE PAIN/Breakthrough pain
1.5. BONE PAIN
2. Emesis
2.1.CANCER-ASSOCIATED EMESIS
2.2.IATROGENIC EMESIS
3. Oncologic Emergencies
3.1. SPINAL COMPRESSION SYNDROME
3.2. SUPERIOR VENA CAVA SYNDROM
3.3. TUMOR HYPERCALCEMIA
3.4. ENDOCRANIAL HYPERTENSION
3.5. ACUTE BLEEDING
3.6. INFUSION REACTIONS
3.7. EMERGENCY KIT
4. Immunotherapy-Associated Toxicity
4.1. IMMUNOTHERAPY-ASSOCIATED TOXICITY
5. Neurological alterations
5.1. ENCEPHALOPATHIES
5.2. WAKEFULNESS-SLEEP RHYTHM DISTURBANCES
5.3. INSOMNIA
5.4. MYELOPATHIES
5.5. PERIPHERAL AND CRANIAL NERVE NEUROPATHY
5.6. DELIRIUM IN CANCER PATIENT
6. Endocrinological alterations
6.1. HYPOPHYSITIS
6.2. DIABETES
6.3. THYROID ALTERATIONS
6.4. ADRENAL ALTERATIONS
6.5. CARCINOID SYNDROME
7. Ophthalmologic disorders
7.1. ECTROPION, ENTROPION
7.2. KERATITIS
7.3. KERATO-CONJUNCTIVITES SICCA
7.4.CONJUNCTIVITIS
8. Oropharyngeal disorders
8.1. OROPHARYNGEAL CANDIDIASIS
8.2. STOMATITIS/MUCOSITIS
8.3. XEROSTOMIA
8.4. ORL SURGERY RECOVERING
9. Gastrointestinal disorders
9.1. DIARRHEA
9.2. INTESTINAL OCCLUSION
9.3. CONSTIPATION
9.4. COLITIS
9.5. POST-RADIATION THERAPY PROCTITIS
10. Hepato-Biliary disorders
10.1.LIVER FAILURE AND CHEMOTHERAPY
10.2. HEPATIC ENCEFALOPATHY
10.3. BILIARY OBSTRUCTION
11. Cardiovascular disorders
11.1. HIGH BLOOD PRESSURE
11.2. CONGESTIVE HEARTH FAILURE
11.3. PERICARDIAL EFFUSION
12. Respiratory disorders
12.1. PULMONARY FIBROSIS
12.2. PNEUMONITIS (Charo Garcia Campelo)
12.3. PLEURAL EFFUSION
12.4. BRONCHIAL HYPERSECRETION
12.5. HEMOPTYSIS
13. Rheumatological alterations
13.1. BONE DISORDERS
13.2. CHEMOTHERAPYS AND HORMONTHERAPY ASSOCIATED RHEUMATIC COMPLICATIONS
13.3. PARANEOPLASTIC RHEUMATIC MANIFESTATIONS
13.4. MALIGNANT DISEASES WITH MUSCULOSKELETAL MANIFESTATIONS
13.5. AUTOANTIBODIES ASSOCIATED TO RHEUMATIC DISEASE IN CANCER PATIENTS
13.6. IMMUNE CHECKPOINT INHIBITOR ASSOCIATED RHEUMATIC CONDITIONS
13.7. RADIOTHERAPY TREATMENT ASSOCIATED RHEUMATIC COMPLICATIONS
14. Constitutional
14.1. CANCER RELATED AND IATROGENIC ASTHENIA
14.2. ANOREXIA CACHEXIA (FALTA CACHEXIA)
15. Nutrition in cancer patients
15.1. NUTRITIONAL RISK PATIENT
15.2. MALNUTRITION IN CANCER PATIENT
16. Genito-urinary disorders
16.1. IATROGENIC MENOPAUSEr>
16.2. ERECTILE DYSFUNCTION
16.3. DYSPAREUNIA AND DECREASED FEMALE LUBRIFICATION
16.4. RADIATION THERAPY INDUCED CYSTITIS
17. Hematological alterations
17.1. ANEMIA
17.2. THROMBOCYTOPENIA
17.3. LEUCOPENIA
17.4. FEBRILE NEUTROPENIC SYNDROME
17.5. BLOOD HYPER VISCOSITY
18. Skin disorders
18.1. RADIATION THERAPY EPITELITIS
18.2. ALOPECIA AND OTHER HAIR IATROGENIC DISORDERS
18.3. SKIN HYPERSENSITIVITY
18.4. PHOTOSENSITIZATION
18.5. HAND-FOOT ERYTRHODYSESTESIA
18.6. UNGUAL ALTERATIONS
18.7. SKIN TOXICITY INDUCED BY TARGETED THERAPIES
19. Metabolic disorders
19.1. DEHYDRATION
19.2. TUMOR LYSIS SYNDROME
19.3. SODIUM METABOLISM
19.4. POTASSIUM METABOLISM
19.5. MAGNESIUM METABOLISM
19.6. CALCIUM METABOLISM
20. Kidney disorders
20.1. PROTEINURIA/NEPHROTIC SYNDROME
20.2. NEFROTOXICITY
21. Kidney Function Assessment
21.1 KIDNEY DISORDERS: RENAL FUNCTION EVALUATION
22. Clotting disorders
22. Clotting disorders
22.1.PULMONARY THROMBOEMBOLISM
22.2. DEEP VEIN THROMBOSIS
22.3. COAGULOPATHY
22.4. DISSEMINATED
INTRAVASCULAR COAGULOPATHY
23. Sedation
23.1. SEDATION IN CANCER PANTIENT
24. Prosthesis and endoprosthesis
24.1. MANAGEMENT OF OBSTRUCTIVE COLON CANCER. SELF-EXPANDING METALLIC STENT VERSUS EMERGENCY SURGERY
25. Surgical Complications
25.1. SEROMAS, BRUISES
25.2. LYMPHEDEMA
25.3. FISTULA
26. Exercice in cancer patients
26.1. EXERCISE IN CANCER PATIENT
27. Other
27.1. FUNGAL INFECTIONS
27.2. BONE METASTASIS
27.3. PERSISTENT HICCUPS
27.4. CANNABIS IN CANCER PATIENT
27.5. CENTRAL VENOUS CATHETER
27.6.VACCINATION IN CANCER PATIENT
27.7. PATHOLOGIC BONE FRACTURES
27. Other
27.8. RISK OF SECOND IATROGENIC TUMORS (LONG SURVIVORS)
27.9. ARTIFICIAL INTELLIGENCE AND SYMPTOMS ASSOCIATED WITH CANCER AND ITS TREATMENTS
27.10.COMMUNICATION WITH CANCER PATIENT AND FAMILY
27.11.ADDRESSING MOURNING AT THE HEALTH CARE PROFESSIONAL
27.12. COVID IN CANCER PATIENT
Previous
Next

The 2nd Edition will consist of 110 chapters. The next compendium will be communicated on our website www.ioncocare.org, and those interested can write to editorial@ioncocare.org where they will be given instructions on how to participate and be accepted as authors.

The 2nd Edition will consist of 110 chapters. The next compendium will be communicated on our website www.ioncocare.org, and those interested can write to editorial@ioncocare.org where they will be given instructions on how to participate and be accepted as authors.

The 2nd Edition will consist of 110 chapters. The next compendium will be communicated on our website www.ioncocare.org, and those interested can write to editorial@ioncocare.org where they will be given instructions on how to participate and be accepted as authors.

Buy the eBook NOW and we will send you the physical book wherever you need it!

FOLLOW US

SPONSOR

CONTACT US

0034 647 630 262

info@ioncocare.org

Valencia, Spain

CONTACT US

0034 647630262

info@ioncocare.org

Valencia, Spain

REMEMBER!!

Buy the eBook NOW and we will send you the physical book wherever you need it!

GO TO THE WEBAPP

Copyright  – INTERNATIONAL  CANCER CARE SUPPORT

IMPORTANT ANNOUNCEMENT: Due to our international expansion, iOncoCare as a brand will be renamed iCCS (International Cancer Care Support) in order to bring more value to our work.

EDITORIAL Publipunt – I.S.B.N: 9788409441525